| TRPM4 |
|---|
| Symbol | TRPM4 |
| Full Name | Transient Receptor Potential Cation Channel Subfamily M Member 4 |
| Chromosome | 19q13.33 |
| NCBI Gene ID | [54795](https://www.ncbi.nlm.nih.gov/gene/54795) |
| OMIM | [606071](https://omim.org/entry/606071) |
| Ensembl | [ENSG00000130589](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000130589) |
| UniProt | [Q9HCF6](https://www.uniprot.org/uniprot/Q9HCF6) |
| Aliases | TRPM4, LTrp4, FLJ90167 |
TRPM4 encodes transient receptor potential cation channel subfamily M member 4, a calcium-activated non-selective cation channel that plays critical roles in various physiological processes. Unlike other TRP channels, TRPM4 is impermeable to calcium — it conducts monovalent cations (primarily Na⁺) and is directly activated by intracellular calcium.
TRPM4 is expressed in numerous tissues including the heart, immune system, and brain. In the heart, it is crucial for cardiac electrical conduction. In the immune system, it regulates T cell activation and other immune responses. In the brain, it is implicated in various neurological conditions including multiple sclerosis, stroke, and potentially neurodegenerative diseases.
TRPM4 is a voltage-dependent, calcium-activated monovalent cation channel with several distinctive properties:
- Calcium activation — Intracellular Ca²⁺ directly activates TRPM4, with activation threshold around 1-10 μM
- Voltage dependence — Channel open probability increases with depolarization
- Ion selectivity — Permeable to Na⁺, K⁺, Cs⁺; impermeable to Ca²⁺ and Mg²⁺
- Desensitization — Prolonged Ca²⁺ exposure leads to channel desensitization
- Single channel conductance — Approximately 75 pS
TRPM4 activity is modulated by multiple mechanisms:
- Intracellular calcium — Primary activator
- Voltage — Depolarization increases open probability
- Phosphorylation — PKC and CaM kinase II can modulate activity
- ATP — Intracellular ATP can inhibit the channel
- pH — Intracellular pH affects channel function
- Calmodulin — Mediates Ca²⁺-dependent activation
flowchart TD
A["TRPM4 Channel"] --> B["Calcium<br/>Activation"]
A --> C["Voltage<br/>Dependence"]
A --> D["Other<br/>Regulators"]
B --> B1["Intracellular Ca²⁺<br/>1-10 μM"]
B1 --> B2["Channel<br/>Opening"]
B2 --> B3["Na⁺ influx<br/>Depolarization"]
C --> C1["Depolarization<br/>increases Popen"]
C1 --> B2
D --> D1["PKC<br/>Phosphorylation"]
D --> D2["ATP<br/>Inhibition"]
D --> D3["pH<br/>Modulation"]
B3 --> E["Cellular<br/>Response"]
B2 --> E
style A fill:#e1f5fe,stroke:#333
style E fill:#c8e6c9,stroke:#333
In the heart, TRPM4 plays essential roles in cardiac electrophysiology:
- Pacemaker activity — Contributes to sinoatrial node automaticity
- Atrioventricular conduction — Modulates AV node conduction
- Ventricular conduction — Affects His-Purkinje system function
- Cardiac myocyte volume — Regulates cell volume changes
- Cardiac remodeling — Involved in pathological remodeling
TRPM4 is expressed in various immune cells and regulates:
- T cell activation — Calcium-dependent activation signals
- B cell function — BCR signaling modulation
- Dendritic cell migration — Chemotaxis
- Macrophage function — Inflammatory responses
In neurons and glia, TRPM4 contributes to:
- Neuronal excitability — Modulates resting membrane potential
- Synaptic transmission — Affects neurotransmitter release
- Neuroprotection — Some evidence for protective roles
- Neuroinflammation — Regulates microglial activation
TRPM4 exhibits broad tissue expression:
- Heart — Atria, ventricles, conduction system
- T cells — Activated T lymphocytes
- Brain — Cortex, hippocampus, cerebellum
- Kidney — Various tubular segments
- Spleen — Immune cells
- Lung — Epithelial cells
- Placenta — Various cell types
- Pancreas — Islet cells
- Liver — Low levels
- Skeletal muscle — Minimal
- Plasma membrane — Primary location
- Endoplasmic reticulum — Some evidence
- Neuronal processes — Axons and dendrites
TRPM4 gain-of-function mutations cause progressive familial heart block:
Progressive Familial Heart Block Type 1 (PFHB1):
- Autosomal dominant inheritance
- Progressive AV conduction disease — From first-degree to complete block
- Atrial fibrillation — Increased risk
- Syncope — Due to bradyarrhythmias
- Pacemaker requirement — Often needed by fourth decade
Mechanism:
- Mutant channels show increased activity
- Enhanced depolarization in conduction system
- Progressive conduction system dysfunction
¶ Multiple Sclerosis and EAE
TRPM4 plays a complex role in neuroinflammation:
Experimental Autoimmune Encephalomyelitis (EAE):
- Increased TRPM4 expression in microglia and neurons during EAE
- Axonal degeneration — TRPM4 contributes to axonal loss
- Neuronal death — Channel mediates excitotoxic damage
- Therapeutic potential — TRPM4 inhibition may be protective
In human MS:
- TRPM4 expression increased in active lesions
- Associated with demyelination and axonal damage
- Potential biomarker and therapeutic target
¶ Stroke and Ischemia
TRPM4 is implicated in stroke pathophysiology:
Ischemic injury:
- TRPM4 activity increases during ischemia
- Contributes to ionic dysregulation
- Aggravates neuronal death
- Blocking TRPM4 is neuroprotective in models
Hemorrhagic stroke:
- Involved in blood-brain barrier disruption
- Modulates edema formation
Emerging evidence links TRPM4 to PD:
- Dopaminergic neurons — TRPM4 expressed in substantia nigra
- α-Synuclein interaction — May affect neuronal vulnerability
- Oxidative stress — TRPM4 may be involved in stress responses
- Therapeutic potential — Targeting TRPM4 may protect neurons
TRPM4 in microglia plays a critical role in neuroinflammation:
- Pro-inflammatory activation — TRPM4 contributes to microglial activation
- Cytokine release — TRPM4 regulates release of inflammatory mediators
- Neurotoxicity — Microglial TRPM4 can mediate neurotoxic effects
- Therapeutic targeting — TRPM4 inhibition may reduce neuroinflammation
TRPM4 genetic variants are associated with disease phenotypes:
- Cardiac conduction variants — Specific SNPs linked to AV block
- Population genetics — Variant frequencies across populations
- Functional studies — How variants affect channel function
- Clinical significance — Implications for risk stratification
- Epilepsy — Altered expression in seizure models
- Migraine — Possible role in trigeminovascular system
- Neuropathic pain — Involvement in pain signaling
TRPM4 significantly impacts neuronal excitability through sodium handling:
- Resting membrane potential — TRPM4 contributes to setting resting potential
- Action potential dynamics — TRPM4 modulates action potential shape
- Firing patterns — TRPM4 influences neuronal firing frequency
- Excitotoxicity — TRPM4 can exacerbate excitotoxic damage
Novel TRPM4-targeted therapies are under development:
- Small molecule inhibitors — Clinical candidates in development
- Peptide blockers — Novel peptide-based inhibitors
- Allosteric modulators — Positive and negative allosteric modulators
- Gene therapy — Silencing approaches for specific applications
TRPM4 is a potential drug target for multiple conditions:
- Antiarrhythmic drugs — TRPM4 blockers for certain arrhythmias
- Heart failure — Modulating conduction system function
- Neuroprotection — TRPM4 inhibitors in stroke and trauma
- MS therapy — Targeting neuroinflammation
- PD prevention — Protecting dopaminergic neurons
- Autoimmune diseases — Modulating T cell responses
- Transplant rejection — Immune suppression strategies
- Small molecule inhibitors — Being developed and tested
- Gene therapy approaches — Targeting TRPM4 expression
- Combination strategies — TRPM4 modulators with other therapies
flowchart TD
A["TRPM4 as<br/>Therapeutic Target"] --> B["Cardiovascular<br/>Diseases"]
A --> C["Neurological<br/>Disorders"]
A --> D["Immune<br/>Conditions"]
B --> B1["Antiarrhythmic<br/>agents"]
B --> B2["Heart block<br/>treatment"]
C --> C1["Stroke<br/>neuroprotection"]
C --> C2["MS<br/>therapy"]
C --> C3["PD<br/>prevention"]
D --> D1["T cell<br/>modulation"]
D --> D2["Autoimmune<br/>approaches"]
B1 --> E["Clinical<br/>Development"]
B2 --> E
C1 --> E
C2 --> E
C3 --> E
D1 --> E
D2 --> E
style A fill:#e1f5fe,stroke:#333
style E fill:#c8e6c9,stroke:#333
TRPM4 mutations cause conduction disease through:
- Enhanced depolarization — Increased Na⁺ influx during action potential
- Altered AV node function — Prolonged conduction times
- Progressive degeneration — Conduction system vulnerability
- Fibrosis — Associated structural changes
TRPM4 contributes to neuroinflammation through:
- Microglial activation — TRPM4 in activated microglia
- Cytokine release — Pro-inflammatory mediator production
- Axonal damage — TRPM4-mediated axonal degeneration
- Demyelination — Oligodendrocyte effects
During stroke, TRPM4 contributes to:
- Ionic imbalance — Disrupted ion homeostasis
- Cell swelling — Osmotic dysregulation
- Excitotoxicity — Enhanced excitotoxic damage
- Inflammation — Post-ischemic inflammatory responses
- Trpm4 knockout mice — Viable with cardiac and immune phenotypes
- Transgenic overexpression — Cardiac-specific effects
- Disease models — EAE, stroke, cardiac conduction disease
- Barbold V et al., J Mol Cell Cardiol 2009 — TRPM4 in cardiac physiology
- Schattling B et al., Nature Medicine 2012 — TRPM4 in EAE and MS
- Bauer M et al., J Mol Cell Cardiol 2012 — TRPM4 in cardiovascular disease
- Guinamard R et al., Exp Physiol 2014 — TRPM4 in cardiovascular system
- Wang Y et al., Neurosci Bull 2021 — TRPM4 in neurological disorders
¶ TRPM4 Channel Structure and Biophysics
TRPM4 is a member of the melastatin subfamily of TRP channels, characterized by its unique structure:
Transmembrane Domain:
- Six transmembrane helices (S1-S6)
- Pore loop between S5 and S6 helices
- Voltage sensor domain (S1-S4)
N-terminal Domain:
- Multiple ankyrin repeat domains (ARD)
- Required for channel tetramerization
- Mediates protein-protein interactions
C-terminal Domain:
- Coil-coil domains for tetramer formation
- Calmodulin binding site
- ATP binding site
¶ Ion Selectivity and Conductance
TRPM4 has distinctive biophysical properties:
Selectivity Filter:
- Non-selective for monovalent cations
- Permeates Na⁺, K⁺, Cs⁺ equally well
- Impermeable to divalent cations (Ca²⁺, Mg²⁺)
- Single channel conductance: ~75 pS
Voltage Dependence:
- Strongly voltage-dependent activation
- Gates open with depolarization
- V½ ≈ +40 mV in physiological conditions
Calcium Activation:
- Direct activation by intracellular Ca²⁺
- Activation threshold: 1-10 μM
- Calmodulin mediates Ca²⁺ sensitivity
TRPM4 gating involves multiple regulatory mechanisms:
Calcium-Dependent Gating:
- Ca²⁺ binds to N-terminal domain
- Calmodulin modulates sensitivity
- Desensitization with prolonged Ca²⁺ exposure
Voltage-Dependent Gating:
- Voltage sensor couples to gate
- Depolarization increases open probability
- S4 helix contains voltage sensors
Modulation by Intracellular Factors:
- ATP: inhibitory at millimolar concentrations
- pH: acidic pH reduces activity
- Phosphorylation: PKC enhances activity
flowchart TD
A["TRPM4 Channel"] --> B["Activation<br/>Stimuli"]
B --> B1["Ca²⁺ binding<br/>1-10 μM"]
B --> B2["Depolarization<br/>Voltage"]
B --> B3["Phosphorylation<br/>PKC"]
B1 --> C["Channel<br/>Opening"]
B2 --> C
B3 --> C
C --> D["Na⁺/K⁺<br/>Conduction"]
D --> E["Cellular<br/>Response"]
style A fill:#e1f5fe,stroke:#333
style E fill:#c8e6c9,stroke:#333
TRPM4 plays crucial roles in cardiac electrical function:
Sinoatrial Node Function:
- Contributes to pacemaker depolarization
- Regulates heart rate through Na⁺ influx
- Modulates automaticity
Atrioventricular Conduction:
- Influences AV node conduction velocity
- Affects PR interval on ECG
- May contribute to AV block
Ventricular Function:
- Modulates His-Purkinje conduction
- Affects ventricular activation
- Contributes to cardiac remodeling
Pathophysiology:
- Gain-of-function mutations cause heart block
- Enhanced TRPM4 activity leads to conduction disease
- Potential antiarrhythmic target
TRPM4 is essential for immune cell function:
T Cell Activation:
- Calcium influx during T cell receptor engagement
- Required for full activation
- Modulates cytokine production
Dendritic Cell Migration:
- Regulates chemotaxis
- Affects antigen presentation
- Guides immune surveillance
Macrophage Function:
- Modulates inflammatory responses
- Regulates phagocytosis
- Controls cytokine release
B Cell Development:
- Affects B cell receptor signaling
- Influences antibody production
- May affect autoimmunity
In the nervous system, TRPM4 regulates:
Membrane Potential:
- Contributes to resting membrane potential
- Modulates neuronal excitability
- Affects action potential threshold
Synaptic Transmission:
- Regulates neurotransmitter release
- Modulates synaptic vesicle dynamics
- Influences synaptic plasticity
Glial Function:
- Present in astrocytes and microglia
- Affects glutamate clearance
- Modulates neuroinflammation
TRPM4 has emerging relevance to PD:
Dopaminergic Neurons:
- TRPM4 is expressed in substantia nigra
- Regulates neuronal calcium homeostasis
- May influence vulnerability to stress
α-Synuclein Pathology:
- Possible interaction with α-synuclein aggregates
- May affect neuronal susceptibility
- Therapeutic targeting being explored
Oxidative Stress:
- TRPM4 responds to oxidative stress
- May contribute to cell death pathways
- Modulation may provide neuroprotection
TRPM4 plays a complex role in MS:
EAE Model Studies:
- TRPM4 expression increases during EAE
- Contributes to axonal degeneration
- Mediates neuronal loss
Microglial Activation:
- TRPM4 in activated microglia
- Regulates cytokine release
- Affects demyelination
Therapeutic Implications:
- TRPM4 inhibition may be protective
- Potential disease-modifying target
- Biomarker potential for disease activity
¶ Stroke and Ischemia
TRPM4 is implicated in stroke pathophysiology:
Ischemic Injury:
- Activity increases during ischemia
- Contributes to ionic dysregulation
- Aggravates neuronal death
Therapeutic Potential:
- Blocking TRPM4 is neuroprotective in models
- Reduces infarct size
- Improves functional recovery
Hemorrhagic Stroke:
- Involved in blood-brain barrier disruption
- Modulates edema formation
- Affects inflammatory responses
TRPM4 may be involved in seizure disorders:
Seizure Models:
- Altered expression in experimental epilepsy
- Contributes to hyperexcitability
- Possible therapeutic target
Mechanism:
- Affects neuronal membrane properties
- Modulates calcium homeostasis
- Influences neurotransmitter release
TRPM4 is a promising drug target:
Inhibitor Development:
- Small molecule TRPM4 blockers in development
- Virtual screening approaches
- Structure-activity relationship studies
Selectivity Challenges:
- Developing selective inhibitors is challenging
- TRPM4 shares structural features with other TRP channels
- Need for subtype-selective compounds
Clinical Candidates:
- Several compounds in preclinical development
- Optimization for brain penetration
- Safety profiling underway
Cardiovascular:
- TRPM4 blockers for arrhythmias
- Treatment for progressive heart block
- Prevention of atrial fibrillation
Neurological:
- Neuroprotection in stroke
- MS disease modification
- PD prevention strategies
Immunological:
- Modulating T cell responses
- Autoimmune disease treatment
- Transplant rejection prevention
flowchart TD
A["TRPM4<br/>Therapeutic Target"] --> B["Cardiovascular<br/>Applications"]
A --> C["Neurological<br/>Applications"]
A --> D["Immunological<br/>Applications"]
B --> B1["Antiarrhythmic<br/>Agents"]
B --> B2["Heart Block<br/>Treatment"]
C --> C1["Stroke<br/>Neuroprotection"]
C --> C2["MS<br/>Disease Modification"]
C --> C3["PD<br/>Prevention"]
D --> D1["T cell<br/>Modulation"]
D --> D2["Autoimmune<br/>Treatment"]
style A fill:#e1f5fe,stroke:#333
style B1 fill:#c8e6c9,stroke:#333
style C1 fill:#c8e6c9,stroke:#333
style D1 fill:#c8e6c9,stroke:#333
¶ Genetics and Variants
TRPM4 mutations cause human disease:
Progressive Familial Heart Block Type 1 (PFHB1):
- Autosomal dominant inheritance
- Gain-of-function mutations
- Progressive conduction system disease
Common Mutations:
- A433T (most common)
- R498W
- V351I
- L888P
Mechanism:
- Mutant channels have increased open probability
- Enhanced depolarization in conduction system
- Progressive degeneration
¶ Genetic Variants and Susceptibility
Polymorphisms may affect disease risk:
Population Studies:
- Certain SNPs associated with arrhythmia risk
- May affect drug response
- Implications for personalized medicine
Functional Variants:
- Some variants affect channel trafficking
- Others alter gating properties
- May influence disease severity
Genetic mouse models reveal TRPM4 function:
Trpm4⁻/⁻ Mice:
- Viable and fertile
- Cardiac phenotypes: bradycardia
- Immune phenotypes: impaired T cell activation
Phenotypes:
- Reduced cardiac conduction velocity
- Impaired immune responses
- Altered neuronal excitability
Overexpression models:
Cardiac-Specific Overexpression:
- Conduction system dysfunction
- Atrial fibrillation
- Heart failure
Neuronal Overexpression:
- Increased seizure susceptibility
- Altered synaptic transmission
- Neuroinflammatory changes
TRPM4 in disease-specific models:
EAE Model:
- TRPM4 contributes to demyelination
- Blocking improves outcomes
- Therapeutic mechanism
Stroke Model:
- TRPM4 knockout reduces injury
- TRPM4 inhibition is protective
- Mechanism: reduced ionic dysregulation
Key questions remain:
- Selectivity — How to develop TRPM4-selective inhibitors?
- Delivery — Can TRPM4 modulators reach the brain?
- Timing — When during disease is targeting most effective?
- Biomarkers — Can TRPM4 serve as disease biomarker?
Key questions remain:
- Selective inhibitors — Developing specific TRPM4 blockers
- Disease mechanisms — Full understanding of TRPM4 pathology
- Biomarkers — TRPM4 as disease biomarker
- Combination therapies — TRPM4 targeting with other approaches